Drug trials

A medical worker gives coronavirus vaccine candidate to a volunteer during a trial at a community health center in Bandung, West Java, Indonesia, Friday, Aug. 14, 2020. Indonesia's only vaccine production company has started this week a so-called phase 3 clinical trials to test a potential coronavirus vaccine developed by a Chinese company. (AP Photo/Kusumadirezza)
August 14, 2020 - 5:52 am
JAKARTA, Indonesia (AP) — More people in Indonesia rolled up their sleeves Friday to test a potential coronavirus vaccine developed by a Chinese company. The Indonesian government announced the partnership between state-owned enterprise Bio Farma and the Chinese company Sinovac BioTech in early...
Read More
In this handout photo taken on Thursday, Aug. 6, 2020, and provided by Russian Direct Investment Fund, a new vaccine is on display at the Nikolai Gamaleya National Center of Epidemiology and Microbiology in Moscow, Russia. Russia on Tuesday, Aug. 11 became the first country to approve a coronavirus vaccine for use in tens of thousands of its citizens despite international skepticism about injections that have not completed clinical trials and were studied in only dozens of people for less than two months. (Alexander Zemlianichenko Jr/ Russian Direct Investment Fund via AP)
August 11, 2020 - 3:35 pm
MOSCOW (AP) — Russia on Tuesday became the first country to approve a coronavirus vaccine, a move that was met with international skepticism and unease because the shots have only been studied in dozens of people. President Vladimir Putin announced the Health Ministry's approval and said one of his...
Read More
A child grimaces as a health worker takes a nasal swab sample for COVID- 19 testing through rapid antigen methodology, in New Delhi, India , Friday, Aug. 7, 2020. As India hit another grim milestone in the coronavirus pandemic on Friday, crossing 2 million cases and more than 41,000 deaths, community health volunteers went on strike complaining they were ill-equipped to respond to the wave of infection in rural areas. (AP Photo/Manish Swarup)
August 07, 2020 - 8:29 am
NEW DELHI (AP) — As India hit another grim milestone in the coronavirus pandemic on Friday, crossing 2 million confirmed cases and more than 41,000 deaths, community health volunteers went on strike complaining they were ill-equipped to respond to the wave of infection in rural areas. Even as India...
Read More
In this photo made from footage provided by the Russian Defense Ministry on Wednesday, July 15, 2020, medical workers in protective gear prepare to draw blood from volunteers participating in a trial of a coronavirus vaccine at the Budenko Main Military Hospital outside Moscow, Russia. Russia is boasting that it’s about to be the first country to approve a COVID-19 vaccine, but scientists worldwide are sounding the alarm that the headlong rush could backfire. (Russian Defense Ministry Press Service via AP)
August 07, 2020 - 3:02 am
MOSCOW (AP) — Russia boasts that it’s about to become the first country to approve a COVID-19 vaccine, with mass vaccinations planned as early as October using shots that are yet to complete clinical trials -- and scientists worldwide are sounding the alarm that the headlong rush could backfire...
Read More
FILE - In this June 16, 2020, file photo, French President Emmanuel Macron listens to a researcher as he visits an industrial development laboratory at French drugmaker's vaccine unit Sanofi Pasteur plant in Marcy-l'Etoile, near Lyon, central France. As the race for a vaccine against the new coronavirus intensifies, many rich countries are rushing to the front of the line by placing advance orders for the inevitably limited supply to guarantee their citizens are immunized first. (AP Photo/Laurent Cipriani, Pool)
July 31, 2020 - 12:46 pm
LONDON (AP) — Pharma giants GlaxoSmithKline and Sanofi Pasteur have announced they will supply 100 million doses of an experimental COVID-19 vaccine to the United States as governments buy up supplies in hopes of securing a candidate that works. The United States will pay up to $2.1 billion “for...
Read More
Leon McFarlane a research technician handles a blood sample from a volunteer in the laboratory at Imperial College in London, Thursday, July 30, 2020. Imperial College is working on the development of a COVID-19 vaccine. Scientists at Imperial College London say they are immunizing hundreds of people with an experimental coronavirus vaccine in an early trial after seeing no worrying safety problems in those vaccinated so far. Dr. Robin Shattock told the Associated Press that he and colleagues had just finished a very slow and arduous process of testing the vaccine at a low dose in a small number of participants and would now be expanding the trial to about 300 people, including those over 75. (AP Photo/Kirsty Wigglesworth)
July 30, 2020 - 3:49 pm
LONDON (AP) — Scientists at Imperial College London say they are immunizing hundreds of people with an experimental coronavirus vaccine in an early trial after seeing no worrying safety problems in a small number vaccinated so far. Dr. Robin Shattock, a professor at the college, told The Associated...
Read More
President Donald Trump speaks during a coronavirus briefing at Bioprocess Innovation Center at Fujifilm Diosynth Biotechnologies, Monday, July 27, 2020, in Morrisville, N.C. (AP Photo/Evan Vucci)
July 27, 2020 - 6:23 pm
WASHINGTON (AP) — President Donald Trump’s handling of the coronavirus pandemic put his political fate in grave jeopardy. Now he’s hoping to get credit for his administration’s aggressive push for a vaccine -– and crossing his fingers that one gets approved before Election Day. Trump and Vice...
Read More
Nurse Kathe Olmstead, right, gives volunteer Melissa Harting, of Harpersville, N.Y., an injection as the world's biggest study of a possible COVID-19 vaccine, developed by the National Institutes of Health and Moderna Inc., gets underway Monday, July 27, 2020, in Binghamton, N.Y. (AP Photo/Hans Pennink)
July 27, 2020 - 10:43 am
The world’s biggest COVID-19 vaccine study got underway Monday with the first of 30,000 planned volunteers helping to test shots created by the U.S. government -- one of several candidates in the final stretch of the global vaccine race. There’s still no guarantee that the experimental vaccine,...
Read More
FILE - In this Wednesday, March 4, 2020 file photo, Jon Ossoff speaks to the media and supporters after he qualified to run in the Senate race against Republican Sen. David Perdue in Atlanta. The Democratic Senate candidate is in isolation as is his wife, who contracted COVID-19, Ossoff confirmed Saturday, July 25, 2020. (Bob Andres/Atlanta Journal-Constitution via AP)
July 25, 2020 - 6:22 pm
ATLANTA -- Georgia Democratic Senate candidate Jon Ossoff says he's in isolation with his wife, who contracted COVID-19. The 33-year-old candidate said his wife, Dr. Alisha Kramer, has mild coronavirus symptoms and that he’s showing symptoms, too. He said he was tested Saturday and is awaiting...
Read More
People wearing face masks to protect against the new coronavirus look at the movable penguin figures on display inside a mall in Beijing, Monday, July 20, 2020. China's latest coronavirus outbreak has spread to a second city in the northwestern region of Xinjiang. (AP Photo/Andy Wong)
July 20, 2020 - 12:40 pm
WASHINGTON — The White House is reviving its public coronavirus task force briefings, and President Donald Trump will again take on a starring role. Trump says he’ll lead a briefing at 5 p.m. Tuesday, his first since April 27. The coronavirus task force, led by Vice President Mike Pence, briefed...
Read More

Pages